Programme Overview

This clinician-led programme combines prescription-based Mounjaro therapy with supportive Weight-Loss Support IV infusions during the advanced stage of the structured weight-management pathway.

Treatment Purpose

The 7.5mg phase helps sustain therapeutic impact during the later stage of treatment while supporting continued metabolic progress within the programme.